abs301.txt	purpose		studies	have	associated	increased	radiation	therapy	(rt)	heart	dose	withcardiac	toxicity	others	correlated	rt-related	immunosuppression	withworsened	survival	given	the	large	vascular	volumes	irradiated	during	locallyadvanced	non-small	cell	lung	cancer	(la-nsclc)	treatment	we	hypothesized	anassociation	between	and	methods	identified	400	la-nsclc	patients	treated	with	definitivert	±	chemotherapy	2001	2016	absolute	lymphocyte	counts	(alc)	neutrophil	(anc)	neutrophil-to-lymphocyte	ratio(nlr	=	anc/alc)	were	analyzed	pre-rt	rt	post-rt	multivariableanalysis	(mva)	was	performed	to	correlate	clinical	factors	both	hematologictoxicity	overall	an	upper	tertile	threshold	increase	specificityof	nlr	chosen	dichotomize	continuous	hematologic	variables	results	median	follow	up	17	months	(range	0	2-174	months)	in	all	patientsand	46	2-161	survivors	a	total	of	94%	hadstage	iii	disease	77%	received	concurrent	chemo	two-year	overallsurvival	(os)	freedom	from	local	recurrence	(fflr)	distantmetastases	(ffdm)	42%	60%	45%	respectively	was18	on	mva	for	os	(n	207)	male	gender	(hazard	ratio	[hr]	1	7	95%	ci1	2-2	3)	alone	(hr	2	ci	9-4	0)	percentage	receiving≥50	gy	(v50)	02	01-1	03)	higher	at	4	reduced	alc	nadir	not	associatedwith	outcomes	>10	5	decreased	(p	<	001)and	ffdm	04)	evaluating	withhematological	247)	adjuvant	6	3-5	p	006)	3	1-12	v50	>25%	(hr2	1-3	02)	conclusion	related	is	worse	patientoutcomes	may	represent	source	mortality	beyond	cardiactoxicity
